- Home
- EHTH vs ANEB Comparison
EHTH vs ANEB Comparison
Compare EHTH & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ANEB
- Stock Information
- Founded
- EHTH 1997
- ANEB 2020
- Country
- EHTH United States
- ANEB United States
- Employees
- EHTH N/A
- ANEB N/A
- Industry
- EHTH Specialty Insurers
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ANEB Health Care
- Exchange
- EHTH Nasdaq
- ANEB Nasdaq
- Market Cap
- EHTH 105.1M
- ANEB 98.6M
- IPO Year
- EHTH 2006
- ANEB 2021
- Fundamental
- Price
- EHTH $4.81
- ANEB $2.30
- Analyst Decision
- EHTH Buy
- ANEB Buy
- Analyst Count
- EHTH 4
- ANEB 2
- Target Price
- EHTH $8.50
- ANEB $8.00
- AVG Volume (30 Days)
- EHTH 320.7K
- ANEB 104.8K
- Earning Date
- EHTH 11-05-2025
- ANEB 11-12-2025
- Dividend Yield
- EHTH N/A
- ANEB N/A
- EPS Growth
- EHTH N/A
- ANEB N/A
- EPS
- EHTH N/A
- ANEB N/A
- Revenue
- EHTH $547,491,000.00
- ANEB N/A
- Revenue This Year
- EHTH $4.88
- ANEB N/A
- Revenue Next Year
- EHTH $3.42
- ANEB N/A
- P/E Ratio
- EHTH N/A
- ANEB N/A
- Revenue Growth
- EHTH 16.19
- ANEB N/A
- 52 Week Low
- EHTH $3.18
- ANEB $0.80
- 52 Week High
- EHTH $11.36
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- EHTH 66.43
- ANEB 49.32
- Support Level
- EHTH $4.03
- ANEB $2.23
- Resistance Level
- EHTH $5.32
- ANEB $2.47
- Average True Range (ATR)
- EHTH 0.30
- ANEB 0.10
- MACD
- EHTH 0.11
- ANEB -0.01
- Stochastic Oscillator
- EHTH 75.25
- ANEB 43.23
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.